Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT

INTRODUCTION: Among treatment-resistant depression (TRD), we identified anergic-anhedonic clinical presentations (TRAD) as putatively responsive to pro-dopaminergic strategies. Based on the literature, non-selective monoamine oxidase inhibitors (MAOI) and dopamine D2 receptor agonists (D2RAG) were s...

Descripción completa

Detalles Bibliográficos
Autores principales: Dormegny-Jeanjean, Ludovic Christophe, de Billy, Clément, Mainberger, Olivier, Weibel, Sébastien, Schorr, Benoit, Obrecht, Alexandre, Landré, Lionel, Berna, Fabrice, Causin, Jean-Baptiste, Blanc, Frederic, Danila, Vlad, Tomsa, Mihaela, Pfleger, Geraldine, Meyer, Camille, Humbert, Ilia, Javelot, Hervé, Meyer, Guillaume, Bertschy, Gilles, Foucher, Jack Rene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565009/
https://www.ncbi.nlm.nih.gov/pubmed/37829759
http://dx.doi.org/10.3389/fpsyt.2023.1194090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565009/
https://www.ncbi.nlm.nih.gov/pubmed/37829759
http://dx.doi.org/10.3389/fpsyt.2023.1194090

Ejemplares similares